Peptic Ulcer Drugs Market Set for Rapid Growth and Trend, by 2022; Says Novartis AG, Ranbaxy Laboratories, Helicure AB
The Global Peptic Ulcer Drugs Market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022.
View full press release